Dow Inc. · NYSE:DOW

Dow — The Dow Chemical Company — Investor Day (December 2012)

18 slides from Dow's investor day presentation, Dec 3, 2012

  1. Slide 1: Bill Weideman, Chief Financial Officer

    Bill Weideman Chief Financial Officer, Executive Vice President December 3, 2012

  2. Slide 2: Agenda

    Agenda  Dow’s Earnings Trajectory  Managing Our Portfolio to Drive Value  Outlook and Key Assumptions  Financial Priorities

  3. Slide 3: Dow's Earnings Trajectory

    Dow’s Earnings Trajectory Interventions Adjusted EBITDA(1) - $B $10.0 Margin / Growth $8.4 Ethylene Cycle $7.5 $7.4 Innovation $5.5 Trailing Near 2009 2010 2011 12 Months(2) Term (1) Adjusted EBITDA is defined as earnings (i.e., “Net Income”) before interest, income taxes, depreciation and amortizat

  4. Slide 4: Market Fundamentals Pressure Price, Margin

    Market Fundamentals Pressure Price, Margin Key Drivers of EBITDA Impact Price/Margin Equity Income  Price / Margin  Equity Income - > $2B price impact - Price erosion in - Price declines and naphtha-based JVs overcapacity - Dow Corning - Weak conditions in ~$200MM decline due Asia Pacific and to r

  5. Slide 5: Agenda

    Agenda  Dow’s Earnings Trajectory  Managing Our Portfolio to Drive Value  Outlook and Key Assumptions  Financial Priorities

  6. Slide 6: Accelerating Cost and Cash Interventions

    Accelerating Cost and Cash Interventions Total Levers: $2.5B Delivering Results Target Savings ($MM) $200MM reduction in Cost Interventions (Run Rate) $1B growth/discretionary spend $1,000 Cash Interventions (Cumulative) Decrease $700MM CapEx reduction $900 CapEx & Growth in 2013* $800 $100MM CapEx

  7. Slide 7: 2013 Cost and Cash Savings

    2013 Cost and Cash Savings 1Q12 4Q12 Growth Discretionary EBITDA Cost Restructuring Restructuring Spending Spending Savings Savings Reduction Reduction Impact Savings $100MM $200MM $100MM $100MM $500MM Adjust CapEx CapEx Cash Prioritize Projects Align Capacity Investment to with Shorter Expansions w

  8. Slide 8: Measuring Progress

    Measuring Progress Total Targeted Impact: $1.75B(1) $1.6B $1.75B(1) 2H13 2H14 Net Headcount Reduction (#) Site Shutdown (#) 3,300(2) 29(2) 1H13 2H13 2H14 1H13 2H13 2H14 CapEx Reduction from 2011 ($MM) Growth / Discretionary Reduction ($MM) $700 $200 1H13 2H13 1H13 2H13 Expect Regular Progress Update

  9. Slide 9: Prioritizing Growth Investments

    Prioritizing Growth Investments Tailoring Growth Spending  Accelerating near-term results  Adjusting investment to reflect new market outlooks  Reduced growth spending by $100MM Market Differentiation Rewarded  Performance Plastics  Electronic Materials  Dow AgroSciences USGC & Sadara Investme

  10. Slide 10: Driving Value Through Organic Growth, ROTC

    Driving Value Through Organic Growth, ROTC Normalized Normalized Trailing 4 Quarters Operating Segment Revenue EBITDA Adjusted EBITDA ROTC(1) Value Driver Growth Target Margin Target Margin(1) Electronic & Functional Materials 2x GDP ~25% 24% Grow Coatings & Infrastructure Solutions 1.5x GDP 20-25%

  11. Slide 11: Interventions by Operating Segment

    Interventions by Operating Segment Revenue EBITDA 2013 Intervention Operating Segment T4Q T4Q Impact Electronic & Functional $4.4B $1.0B ~$75MM Materials Coatings & Infrastructure $6.9B $1.1B ~$100MM Solutions Agricultural Sciences $6.2B $1.0B ~$25MM Performance Materials $13.8B $1.7B ~$100MM Perfor

  12. Slide 12: Focused Portfolio Management

    Focused Portfolio Management Operating Segment Actions Electronic & Functional  Focus investments in fastest growing markets Grow Materials  Align programs with technology-intensive industries Coatings & Infrastructure  Asset and workforce restructuring Improve Solutions  Reset growth programs t

  13. Slide 13: Agenda

    Agenda  Dow’s Earnings Trajectory  Managing Our Portfolio to Drive Value  Outlook and Key Assumptions  Financial Priorities

  14. Slide 14: Dow's Near-Term Assumptions

    Dow’s Near-Term Assumptions Dow Assumptions Current Macroeconomic Uncertainties  Global real GDP: ~2-2.5%  Europe – Solvency and liquidity issues – U.S.: ~2%  U.S. – Persistent high unemployment, – Europe: decline ~0.5% high debt levels, and fiscal cliff concerns – China and India: ~6-7%  Asia –

  15. Slide 15: Agenda

    Agenda  Dow’s Earnings Trajectory  Managing Our Portfolio to Drive Value  Outlook and Key Assumptions  Financial Priorities

  16. Slide 16: Enhancing Financial Flexibility

    Enhancing Financial Flexibility YTD Cash Flow from Operations Significant Debt Reduction Improvement in Total Liquidity* 60.0% Net Debt / EBITDA 5 4.5x $12 $3.0 4 50.0% 48.3% $10 $2.5 40.0% 51.1% 43.8% $2.0 39.7% 3 $8 30.0% 2.5x 2.2x 2 $B $B $1.5 2.0x $6 20.0% $1.0 $4 10.0% Net Debt / Total Cap 1 $0

  17. Slide 17: Near-Term Financial Priorities

    Near-Term Financial Priorities Protect Enhance Reward Earnings Foundation Financial Flexibility Shareholders  Deliver $1B in cost  Further reduce debt –  Improve ROC and cash interventions Target net debt to  Consistently reward in 2013 EBITDA ~2x shareholders  Reduce growth &  Drive increase

  18. Slide 18: Slide 18

The Dow Chemical Company — Investor Day (December 2012) on 6ix